1. Allard, J; BarrĂ³n, S; Diaz, J; Lubetzki, C; Zalc, B; Schwartz, JC; Sokoloff, P. (1998) A rat G protein-coupled receptor selectively expressed in myelin-forming cells.
Eur. J. Neurosci., 10 (3): 1045-53.
[PMID:9753172]
2. Bandoh, K; Aoki, J; Taira, A; Tsujimoto, M; Arai, H; Inoue, K. (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
FEBS Lett., 478 (1-2): 159-65.
[PMID:10922489]
3. Choi, JW; Herr, DR; Noguchi, K; Yung, YC; Lee, CW; Mutoh, T; Lin, ME; Teo, ST; Park, KE; Mosley, AN; Chun, J. (2010) LPA receptors: subtypes and biological actions.
Annu. Rev. Pharmacol. Toxicol., 50: 157-86.
[PMID:20055701]
4. Contos, JJ; Fukushima, N; Weiner, JA; Kaushal, D; Chun, J. (2000) Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.
Proc. Natl. Acad. Sci. U.S.A., 97 (24): 13384-9.
[PMID:11087877]
5. Dubin, AE; Bahnson, T; Weiner, JA; Fukushima, N; Chun, J. (1999) Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts.
J. Neurosci., 19 (4): 1371-81.
[PMID:9952414]
6. Fischer, DJ; Nusser, N; Virag, T; Yokoyama, K; Wang Da; Baker, DL; Bautista, D; Parrill, AL; Tigyi, G. (2001) Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors.
Mol. Pharmacol., 60 (4): 776-84.
[PMID:11562440]
7. Heasley, BH; Jarosz, R; Lynch, KR; Macdonald, TL. (2004) Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
Bioorg. Med. Chem. Lett., 14 (11): 2735-40.
[PMID:15125924]
8. Hecht, JH; Weiner, JA; Post, SR; Chun, J. (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex.
J. Cell Biol., 135 (4): 1071-83.
[PMID:8922387]
9. Heise, CE; Santos, WL; Schreihofer, AM; Heasley, BH; Mukhin, YV; Macdonald, TL; Lynch, KR. (2001) Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist.
Mol. Pharmacol., 60 (6): 1173-80.
[PMID:11723223]
10. Ohta, H; Sato, K; Murata, N; Damirin, A; Malchinkhuu, E; Kon, J; Kimura, T; Tobo, M; Yamazaki, Y; Watanabe, T; Yagi, M; Sato, M; Suzuki, R; Murooka, H; Sakai, T; Nishitoba, T; Im, DS; Nochi, H; Tamoto, K; Tomura, H; Okajima, F. (2003) Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Mol. Pharmacol., 64 (4): 994-1005.
[PMID:14500756]
11. Qian, L; Xu, Y; Simper, T; Jiang, G; Aoki, J; Umezu-Goto, M; Arai, H; Yu, S; Mills, GB; Tsukahara, R; et al.. (2006) Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
ChemMedChem, 1 (3): 376-83.
[PMID:16892372]
12. Swaney, JS; Chapman, C; Correa, LD; Stebbins, KJ; Bundey, RA; Prodanovich, PC; Fagan, P; Baccei, CS; Santini, AM; Hutchinson, JH; et al.. (2010) A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
Br. J. Pharmacol., 160 (7): 1699-713.
[PMID:20649573]
13. Yang, AH; Ishii, I; Chun, J. (2002) In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice.
Biochim. Biophys. Acta, 1582 (1-3): 197-203.
[PMID:12069829]